However, another study showed that NOD2 antagonist inhibited both NF-κB and MAPK inflammatory signaling, and played an adjuvant role to paclitaxel (PTX) to suppress Lewis lung carcinoma (LLC) growth45. Here, NFKB1 is linked to Carcinoma, Lewis Lung.